{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T15:57:29Z","timestamp":1786550249611,"version":"build-2736575974"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T00:00:00Z","timestamp":1768262400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:00:00Z","timestamp":1770249600000},"content-version":"vor","delay-in-days":23,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","award":["No. 855923"],"award-info":[{"award-number":["No. 855923"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","award":["No. 855923"],"award-info":[{"award-number":["No. 855923"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"name":"NextGenerationEU PNRR MUR\u2014 M4C2\u2014Action","award":["CUP J33C22001130001"],"award-info":[{"award-number":["CUP J33C22001130001"]}]},{"DOI":"10.13039\/100018703","name":"European Innovation Council","doi-asserted-by":"crossref","award":["No. 101098989"],"award-info":[{"award-number":["No. 101098989"]}],"id":[{"id":"10.13039\/100018703","id-type":"DOI","asserted-by":"crossref"}]},{"name":"MUR PRIN 2022","award":["CUP: 2022CFP7RF"],"award-info":[{"award-number":["CUP: 2022CFP7RF"]}]},{"name":"MUR PRIN 2022","award":["CUP: 2022CFP7RF"],"award-info":[{"award-number":["CUP: 2022CFP7RF"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-35383-y","type":"journal-article","created":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T02:23:04Z","timestamp":1768270984000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Non-invasive screening of alzheimer\u2019s disease via label-free tri-spectral retinal imaging"],"prefix":"10.1038","volume":"16","author":[{"given":"Zita","family":"Salajkov\u00e1","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Ciasca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Di Lorenzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryamsadat","family":"Ghoreishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Reale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Grazia","family":"Gambarota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanxing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Ricco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giancarlo","family":"Ruocco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Leonetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,13]]},"reference":[{"key":"35383_CR1","doi-asserted-by":"publisher","first-page":"e105","DOI":"10.1016\/S2468-2667(21)00249-8","volume":"7","author":"E Nichols","year":"2022","unstructured":"Nichols, E. et al. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the global burden of disease study 2019. Lancet Public. Heal. 7, e105\u2013e125. https:\/\/doi.org\/10.1016\/S2468-2667(21)00249-8 (2022).","journal-title":"Lancet Public. Heal"},{"key":"35383_CR2","doi-asserted-by":"publisher","unstructured":"Grimaldi, A. et al. Inflammation, neurodegeneration and protein aggregation in the retina as ocular biomarkers for alzheimer\u2019s disease in the 3xTg-AD mouse model. Cell. Death Dis. 9 https:\/\/doi.org\/10.1038\/s41419-018-0740-5 (2018).","DOI":"10.1038\/s41419-018-0740-5"},{"key":"35383_CR3","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/BF00308809","volume":"82","author":"H Braak","year":"1991","unstructured":"Braak, H. & Braak, E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 82, 239\u2013259 (1991).","journal-title":"Acta Neuropathol."},{"key":"35383_CR4","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1016\/j.neuron.2014.05.004","volume":"82","author":"TL Spires-Jones","year":"2014","unstructured":"Spires-Jones, T. L. & Hyman, B. T. The intersection of amyloid beta and Tau at synapses in alzheimer\u2019s disease. Neuron 82, 756\u2013771 (2014).","journal-title":"Neuron"},{"key":"35383_CR5","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1002\/alz.12189","volume":"17","author":"DL Francesco","year":"2021","unstructured":"Francesco, D. L. & Koch, G. Synaptic impairment: the new battlefield of alzheimer\u2019s disease. Alzheimer\u2019s Dement. 17, 314\u2013315. https:\/\/doi.org\/10.1002\/alz.12189 (2021).","journal-title":"Alzheimer\u2019s Dement."},{"key":"35383_CR6","doi-asserted-by":"publisher","unstructured":"Yiannopoulou, K. G. & Papageorgiou, S. G. Current and future treatments in alzheimer disease: an update. J. Cent. Nerv. Syst. Dis. 12 https:\/\/doi.org\/10.1177\/1179573520907397 (2020).","DOI":"10.1177\/1179573520907397"},{"key":"35383_CR7","doi-asserted-by":"publisher","first-page":"4757","DOI":"10.1016\/j.cell.2023.09.023","volume":"186","author":"AL Boxer","year":"2023","unstructured":"Boxer, A. L. & Sperling, R. Accelerating alzheimer\u2019s therapeutic development: the past and future of clinical trials. Cell 186, 4757\u20134772. https:\/\/doi.org\/10.1016\/j.cell.2023.09.023 (2023).","journal-title":"Cell"},{"key":"35383_CR8","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s40259-023-00633-2","volume":"38","author":"J Cummings","year":"2024","unstructured":"Cummings, J. et al. Anti-Amyloid monoclonal antibodies for the treatment of alzheimer\u2019s disease. BioDrugs 38, 5\u201322. https:\/\/doi.org\/10.1007\/s40259-023-00633-2 (2024).","journal-title":"BioDrugs"},{"key":"35383_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pbio.3001694","volume":"20","author":"C Haass","year":"2022","unstructured":"Haass, C. & Selkoe, D. If amyloid drives alzheimer disease, why have anti-amyloid therapies not yet slowed cognitive decline? PLoS Biol. 20, 1\u201315. https:\/\/doi.org\/10.1371\/journal.pbio.3001694 (2022).","journal-title":"PLoS Biol."},{"key":"35383_CR10","doi-asserted-by":"publisher","first-page":"e413","DOI":"10.1097\/RLU.0000000000000547","volume":"39","author":"C Marcus","year":"2014","unstructured":"Marcus, C., Mena, E. & Subramaniam, R. M. Brain PET in the diagnosis of alzheimer\u2019s disease. Clin. Nucl. Med. 39, e413. https:\/\/doi.org\/10.1097\/RLU.0000000000000547 (2014).","journal-title":"Clin. Nucl. Med."},{"key":"35383_CR11","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1002\/alz.12372","volume":"18","author":"H Hampel","year":"2022","unstructured":"Hampel, H. et al. State-of-the-art of lumbar puncture and its place in the journey of patients with alzheimer\u2019s disease. Alzheimer\u2019s Dement. 18, 159\u2013177 (2022).","journal-title":"Alzheimer\u2019s Dement."},{"key":"35383_CR12","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s12149-020-01453-y","volume":"34","author":"T Thientunyakit","year":"2020","unstructured":"Thientunyakit, T. et al. Relationships between amyloid levels, glucose metabolism, morphologic changes in the brain and clinical status of patients with alzheimer\u2019s disease. Ann. Nucl. Med. 34, 337\u2013348. https:\/\/doi.org\/10.1007\/s12149-020-01453-y (2020).","journal-title":"Ann. Nucl. Med."},{"key":"35383_CR13","doi-asserted-by":"publisher","unstructured":"Weller, J. & Budson, A. Current Understanding of alzheimer\u2019s disease diagnosis and treatment. F1000Research 7 https:\/\/doi.org\/10.12688\/F1000RESEARCH.14506.1 (2018).","DOI":"10.12688\/F1000RESEARCH.14506.1"},{"key":"35383_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/dad2.70068","volume":"17","author":"A Antonioni","year":"2025","unstructured":"Antonioni, A. et al. Blood phosphorylated Tau181 reliably differentiates amyloid-positive from amyloid-negative subjects in the alzheimer\u2019s disease continuum: A systematic review and meta-analysis. Alzheimer\u2019s Dement. Diagnosis Assess. Dis. Monit. 17, 1\u201315. https:\/\/doi.org\/10.1002\/dad2.70068 (2025).","journal-title":"Alzheimer\u2019s Dement. Diagnosis Assess. Dis. Monit."},{"key":"35383_CR15","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-025-12996-3","author":"A Antonioni","year":"2025","unstructured":"Antonioni, A. et al. Blood phosphorylated Tau217 distinguishes amyloid \u2013 positive from amyloid \u2013 negative subjects in the alzheimer \u2019 s disease continuum. A systematic review and meta \u2013 analysis. J. Neurol. https:\/\/doi.org\/10.1007\/s00415-025-12996-3 (2025).","journal-title":"J. Neurol."},{"key":"35383_CR16","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/S1474-4422(21)00361-6","volume":"21","author":"CE Teunissen","year":"2022","unstructured":"Teunissen, C. E. et al. Blood-based biomarkers for alzheimer\u2019s disease: towards clinical implementation. Lancet Neurol. 21, 66\u201377. https:\/\/doi.org\/10.1016\/S1474-4422(21)00361-6 (2022).","journal-title":"Lancet Neurol."},{"key":"35383_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-024-02709-z","author":"TR Hunter","year":"2024","unstructured":"Hunter, T. R., Santos, L. E., Tovar-Moll, F. & De Felice, F. G. Alzheimer\u2019s disease biomarkers and their current use in clinical research and practice. Mol. Psychiatry. https:\/\/doi.org\/10.1038\/s41380-024-02709-z (2024).","journal-title":"Mol. Psychiatry"},{"key":"35383_CR18","doi-asserted-by":"publisher","first-page":"2471","DOI":"10.1007\/s10072-023-07258-x","volume":"45","author":"A Antonioni","year":"2024","unstructured":"Antonioni, A., Raho, E. M. & Di Lorenzo, F. Is blood pTau a reliable indicator of the CSF status? A narrative review. Neurol. Sci. 45, 2471\u20132487. https:\/\/doi.org\/10.1007\/s10072-023-07258-x (2024).","journal-title":"Neurol. Sci."},{"key":"35383_CR19","doi-asserted-by":"publisher","unstructured":"Mirzaei, N. et al. Alzheimer\u2019s retinopathy: seeing disease in the eyes. Front. Neurosci. 14 https:\/\/doi.org\/10.3389\/FNINS.2020.00921 (2020).","DOI":"10.3389\/FNINS.2020.00921"},{"key":"35383_CR20","doi-asserted-by":"publisher","unstructured":"Grimaldi, A. et al. Neuroinflammatory Processes, A1 astrocyte activation and protein aggregation in the retina of alzheimer\u2019s disease Patients, possible biomarkers for early diagnosis. Front. Neurosci. 13 https:\/\/doi.org\/10.3389\/fnins.2019.00925 (2019).","DOI":"10.3389\/fnins.2019.00925"},{"key":"35383_CR21","doi-asserted-by":"publisher","first-page":"101273","DOI":"10.1016\/j.preteyeres.2024.101273","volume":"101","author":"BP Gaire","year":"2024","unstructured":"Gaire, B. P. et al. Alzheimer\u2019s disease pathophysiology in the retina. Prog Retin Eye Res. 101, 101273. https:\/\/doi.org\/10.1016\/j.preteyeres.2024.101273 (2024).","journal-title":"Prog Retin Eye Res."},{"key":"35383_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2174\/1567209197155452050","volume":"999","author":"L Guo","year":"2009","unstructured":"Guo, L. Alzheimer\u2019s disease and retinal neurodegeneration. Curr. Alzheimer Res. 999, 1\u20136. https:\/\/doi.org\/10.2174\/1567209197155452050 (2009).","journal-title":"Curr. Alzheimer Res."},{"key":"35383_CR23","doi-asserted-by":"publisher","first-page":"100899","DOI":"10.1016\/j.preteyeres.2020.100899","volume":"82","author":"VB Gupta","year":"2021","unstructured":"Gupta, V. B. et al. Retinal changes in alzheimer\u2019s disease\u2014 integrated prospects of imaging, functional and molecular advances. Prog Retin Eye Res. 82, 100899 (2021).","journal-title":"Prog Retin Eye Res."},{"key":"35383_CR24","doi-asserted-by":"publisher","unstructured":"Hadoux, X. et al. Non-invasive in vivo hyperspectral imaging of the retina for potential biomarker use in alzheimer\u2019s disease. Nat. Commun. 10 https:\/\/doi.org\/10.1038\/S41467-019-12242-1 (2019).","DOI":"10.1038\/S41467-019-12242-1"},{"key":"35383_CR25","doi-asserted-by":"publisher","unstructured":"Chan, V. T. T. et al. Value proposition of retinal imaging in alzheimer\u2019s disease screening: A review of eight evolving trends. Prog Retin Eye Res. 103 https:\/\/doi.org\/10.1016\/j.preteyeres.2024.101290 (2024).","DOI":"10.1016\/j.preteyeres.2024.101290"},{"key":"35383_CR26","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1159\/000335154","volume":"10","author":"Y Koronyo","year":"2012","unstructured":"Koronyo, Y., Salumbides, B. C., Black, K. L. & Koronyo-Hamaoui, M. Alzheimer\u2019s disease in the retina: imaging retinal A\u03b2 plaques for early diagnosis and therapy assessment. Neurodegener Dis. 10, 285\u2013293. https:\/\/doi.org\/10.1159\/000335154 (2012).","journal-title":"Neurodegener Dis."},{"key":"35383_CR27","doi-asserted-by":"publisher","unstructured":"Koronyo-Hamaoui, M. et al. Identification of amyloid plaques in retinas from alzheimer\u2019s patients and noninvasive in vivo optical imaging of retinal plaques in a mouse model. Neuroimage 54 https:\/\/doi.org\/10.1016\/j.neuroimage.2010.06.020 (2011).","DOI":"10.1016\/j.neuroimage.2010.06.020"},{"key":"35383_CR28","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1111\/j.1471-4159.2007.04613.x","volume":"102","author":"M Garcia-Alloza","year":"2007","unstructured":"Garcia-Alloza, M. et al. Curcumin labels amyloid pathology in vivo, disrupts existing plaques, and partially restores distorted neurites in an alzheimer mouse model. J. Neurochem. 102, 1095\u20131104. https:\/\/doi.org\/10.1111\/j.1471-4159.2007.04613.x (2007).","journal-title":"J. Neurochem"},{"key":"35383_CR29","doi-asserted-by":"publisher","unstructured":"Koronyo, Y. et al. Retinal amyloid pathology and proof-of-concept imaging trial in Alzheimer\u2019s disease. JCI Insight. 2 https:\/\/doi.org\/10.1172\/JCI.INSIGHT.93621 (2017).","DOI":"10.1172\/JCI.INSIGHT.93621"},{"key":"35383_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/dad2.12347","volume":"14","author":"J den Haan","year":"2022","unstructured":"den Haan, J. et al. loid-proven AD cases compared to controls. Alzheimer\u2019s Dement. Diagnosis Assess. Dis. Monit. 14, 1\u201310. https:\/\/doi.org\/10.1002\/dad2.12347 (2022).","journal-title":"Alzheimer\u2019s Dement. Diagnosis Assess. Dis. Monit."},{"key":"35383_CR31","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.jcrs.2009.08.035","volume":"36","author":"L Kessel","year":"2010","unstructured":"Kessel, L. et al. Age-related changes in the transmission properties of the human lens and their relevance to circadian entrainment. J. Cataract Refract. Surg. 36, 308\u2013312. https:\/\/doi.org\/10.1016\/j.jcrs.2009.08.035 (2010).","journal-title":"J. Cataract Refract. Surg."},{"key":"35383_CR32","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1097\/WNO.0000000000001786","volume":"43","author":"MY Tang","year":"2023","unstructured":"Tang, M. Y. et al. Imaging amyloid and Tau in the retina: current research and future directions. J. Neuro-Ophthalmology. 43, 168\u2013179. https:\/\/doi.org\/10.1097\/WNO.0000000000001786 (2023).","journal-title":"J. Neuro-Ophthalmology"},{"key":"35383_CR33","doi-asserted-by":"publisher","unstructured":"More, S. S. et al. In Vivo Assessment of Retinal Biomarkers by Hyperspectral Imaging: Early Detection of Alzheimer\u2019s Disease. (2019). https:\/\/doi.org\/10.1021\/acschemneuro.9b00331","DOI":"10.1021\/acschemneuro.9b00331"},{"key":"35383_CR34","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1021\/CN500242Z\/SUPPL_FILE\/CN500242Z_SI_001.PDF","volume":"6","author":"SS More","year":"2015","unstructured":"More, S. S. & Vince, R. Hyperspectral imaging signatures detect amyloidopathy in alzheimers mouse retina well before onset of cognitive decline. ACS Chem. Neurosci. 6, 306\u2013315. https:\/\/doi.org\/10.1021\/CN500242Z\/SUPPL_FILE\/CN500242Z_SI_001.PDF (2015).","journal-title":"ACS Chem. Neurosci."},{"key":"35383_CR35","doi-asserted-by":"publisher","unstructured":"Saeed, A., Hadoux, X. & van Wijngaarden, P. Hyperspectral retinal imaging biomarkers of ocular and systemic diseases. Eye 1\u20136. (2024). https:\/\/doi.org\/10.1038\/s41433-024-03135-9","DOI":"10.1038\/s41433-024-03135-9"},{"key":"35383_CR36","doi-asserted-by":"publisher","first-page":"3231","DOI":"10.1167\/IOVS.15-17406","volume":"57","author":"SS More","year":"2016","unstructured":"More, S. S., Beach, J. M. & Vince, R. Early detection of amyloidopathy in alzheimer\u2019s mice by hyperspectral endoscopy. Invest. Ophthalmol. Vis. Sci. 57, 3231\u20133238. https:\/\/doi.org\/10.1167\/IOVS.15-17406 (2016).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"35383_CR37","doi-asserted-by":"publisher","first-page":"e806","DOI":"10.1016\/S2589-7500(22)00169-8","volume":"4","author":"CY Cheung","year":"2022","unstructured":"Cheung, C. Y. et al. A deep learning model for detection of alzheimer\u2019s disease based on retinal photographs: a retrospective, multicentre case-control study. Lancet Digit. Heal. 4, e806\u2013e815. https:\/\/doi.org\/10.1016\/S2589-7500(22)00169-8 (2022).","journal-title":"Lancet Digit. Heal"},{"key":"35383_CR38","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1136\/bjophthalmol-2020-317659","volume":"106","author":"CE Wisely","year":"2022","unstructured":"Wisely, C. E. et al. Convolutional neural network to identify symptomatic alzheimer\u2019s disease using multimodal retinal imaging. Br. J. Ophthalmol. 106, 388\u2013395. https:\/\/doi.org\/10.1136\/bjophthalmol-2020-317659 (2022).","journal-title":"Br. J. Ophthalmol."},{"key":"35383_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-020-80312-2","volume":"11","author":"J Tian","year":"2021","unstructured":"Tian, J. et al. Modular machine learning for alzheimer\u2019s disease classification from retinal vasculature. Sci. Rep. 11, 1\u201311. https:\/\/doi.org\/10.1038\/s41598-020-80312-2 (2021).","journal-title":"Sci. Rep."},{"key":"35383_CR40","doi-asserted-by":"publisher","unstructured":"Du, X. et al. Label-Free Hyperspectral Imaging and Deep-Learning Prediction of Retinal Amyloid \u03b2-Protein and Phosphorylated Tau. 2022 IEEE Photonics Conf IPC 2022 - Proc 1\u201323. (2022). https:\/\/doi.org\/10.1109\/IPC53466.2022.9975636","DOI":"10.1109\/IPC53466.2022.9975636"},{"key":"35383_CR41","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.chemolab.2015.05.021","volume":"146","author":"X Hadoux","year":"2015","unstructured":"Hadoux, X., Rutledge, D. N., Rabatel, G. & Roger, J. M. DROP-D: dimension reduction by orthogonal projection for discrimination. Chemom Intell. Lab. Syst. 146, 221\u2013231. https:\/\/doi.org\/10.1016\/j.chemolab.2015.05.021 (2015).","journal-title":"Chemom Intell. Lab. Syst."},{"key":"35383_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/life12070973","volume":"12","author":"S Biswas","year":"2022","unstructured":"Biswas, S. et al. Which color channel is better for diagnosing retinal diseases automatically in color. Fundus Photographs? Life. 12, 1\u201338. https:\/\/doi.org\/10.3390\/life12070973 (2022).","journal-title":"Fundus Photographs? Life"},{"key":"35383_CR43","first-page":"273","volume":"46","author":"D Enderle","year":"2022","unstructured":"Enderle, D. & Noerholm, M. Are extracellular vesicles ready for the clinical laboratory? LaboratoriumsMedizin 46, 273\u2013282 (2022).","journal-title":"LaboratoriumsMedizin"},{"key":"35383_CR44","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/S0039-6257(01)00234-X","volume":"46","author":"TY Wong","year":"2001","unstructured":"Wong, T. Y. et al. Retinal microvascular abnormalities and their relationship with hypertension, cardiovascular disease, and mortality. Surv. Ophthalmol. 46, 59\u201380. https:\/\/doi.org\/10.1016\/S0039-6257(01)00234-X (2001).","journal-title":"Surv. Ophthalmol."},{"key":"35383_CR45","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","volume":"14","author":"CR Jack","year":"2018","unstructured":"Jack, C. R. et al. NIA-AA research framework: toward a biological definition of alzheimer\u2019s disease. Alzheimer\u2019s Dement. 14, 535\u2013562. https:\/\/doi.org\/10.1016\/j.jalz.2018.02.018 (2018).","journal-title":"Alzheimer\u2019s Dement."},{"key":"35383_CR46","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/S1474-4422(20)30314-8","volume":"19","author":"G Ch\u00e9telat","year":"2020","unstructured":"Ch\u00e9telat, G. et al. Amyloid-PET and 18F-FDG-PET in the diagnostic investigation of alzheimer\u2019s disease and other dementias. Lancet Neurol. 19, 951\u2013962. https:\/\/doi.org\/10.1016\/S1474-4422(20)30314-8 (2020).","journal-title":"Lancet Neurol."},{"key":"35383_CR47","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1007\/s40120-023-00526-0","volume":"12","author":"P Chaitanuwong","year":"2023","unstructured":"Chaitanuwong, P. et al. Potential ocular biomarkers for early detection of alzheimer\u2019s disease and their roles in artificial intelligence studies. Neurol. Ther. 12, 1517\u20131532. https:\/\/doi.org\/10.1007\/s40120-023-00526-0 (2023).","journal-title":"Neurol. Ther."},{"key":"35383_CR48","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1186\/s12967-023-04720-4","volume":"21","author":"V Zelli","year":"2023","unstructured":"Zelli, V. et al. Classification of tumor types using XGBoost machine learning model: a vector space transformation of genomic alterations. J. Transl Med. 21, 836 (2023).","journal-title":"J. Transl Med."},{"key":"35383_CR49","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1186\/s12967-022-03369-9","volume":"20","author":"Q Li","year":"2022","unstructured":"Li, Q. et al. XGBoost-based and tumor-immune characterized gene signature for the prediction of metastatic status in breast cancer. J. Transl Med. 20, 177 (2022).","journal-title":"J. Transl Med."},{"key":"35383_CR50","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s12911-023-02238-9","volume":"23","author":"F Yi","year":"2023","unstructured":"Yi, F. et al. XGBoost-SHAP-based interpretable diagnostic framework for alzheimer\u2019s disease. BMC Med. Inf. Decis. Mak. 23, 137 (2023).","journal-title":"BMC Med. Inf. Decis. Mak."},{"key":"35383_CR51","doi-asserted-by":"crossref","unstructured":"Chen, T. & Guestrin, C. Xgboost: A scalable tree boosting system. In: Proceedings of the 22nd acm sigkdd international conference on knowledge discovery and data mining. pp 785\u2013794 (2016).","DOI":"10.1145\/2939672.2939785"},{"key":"35383_CR52","doi-asserted-by":"publisher","first-page":"110861","DOI":"10.1016\/j.clinbiochem.2024.110861","volume":"135","author":"V Carnazzo","year":"2025","unstructured":"Carnazzo, V. et al. Exploratory study of extracellular matrix biomarkers for non-invasive liver fibrosis staging: A machine learning approach with XGBoost and explainable AI. Clin. Biochem. 135, 110861 (2025).","journal-title":"Clin. Biochem."},{"key":"35383_CR53","first-page":"4766","volume":"2017-Decem","author":"SM Lundberg","year":"2017","unstructured":"Lundberg, S. M. & Lee, S. I. A unified approach to interpreting model predictions. Adv. Neural Inf. Process. Syst. 2017-Decem, 4766\u20134775 (2017).","journal-title":"Adv. Neural Inf. Process. Syst."},{"key":"35383_CR54","doi-asserted-by":"publisher","first-page":"7792","DOI":"10.1038\/s41598-025-92565-w","volume":"15","author":"Z Salajkov\u00e1","year":"2025","unstructured":"Salajkov\u00e1, Z. et al. Optical signature of retinal Tau fibrillation. Sci. Rep. 15, 7792. https:\/\/doi.org\/10.1038\/s41598-025-92565-w (2025).","journal-title":"Sci. Rep."},{"key":"35383_CR55","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1080\/02713683.2019.1565890","volume":"44","author":"K Peynshaert","year":"2019","unstructured":"Peynshaert, K. et al. Morphology and composition of the inner limiting membrane: Species-Specific variations and relevance toward drug delivery research. Curr. Eye Res. 44, 465\u2013475. https:\/\/doi.org\/10.1080\/02713683.2019.1565890 (2019).","journal-title":"Curr. Eye Res."},{"key":"35383_CR56","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1159\/000444508","volume":"235","author":"F Vielmuth","year":"2016","unstructured":"Vielmuth, F. et al. Biomechanical properties of the internal limiting membrane after intravitreal ocriplasmin treatment. Ophthalmologica 235, 233\u2013240. https:\/\/doi.org\/10.1159\/000444508 (2016).","journal-title":"Ophthalmologica"},{"key":"35383_CR57","doi-asserted-by":"publisher","unstructured":"Mazzini, A. et al. A time-dependent study of nano-mechanical and ultrastructural properties of internal limiting membrane under ocriplasmin treatment. J. Mech. Behav. Biomed. Mater. 110:Art Number. 103853 https:\/\/doi.org\/10.1016\/j.jmbbm.2020.103853 (2020).","DOI":"10.1016\/j.jmbbm.2020.103853"},{"key":"35383_CR58","doi-asserted-by":"publisher","first-page":"e0220571","DOI":"10.1371\/journal.pone.0220571","volume":"14","author":"G Ciasca","year":"2019","unstructured":"Ciasca, G. et al. Nanomechanical mapping helps explain differences in outcomes of eye microsurgery: A comparative study of macular pathologies. PLoS One. 14, e0220571. https:\/\/doi.org\/10.1371\/journal.pone.0220571 (2019).","journal-title":"PLoS One"},{"key":"35383_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0134750","volume":"10","author":"G Coppola","year":"2015","unstructured":"Coppola, G. et al. Optical coherence tomography in alzheimer\u2019s disease: A meta-analysis. PLoS One. 10, 1\u201314. https:\/\/doi.org\/10.1371\/journal.pone.0134750 (2015).","journal-title":"PLoS One"},{"key":"35383_CR60","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.dadm.2016.12.014","volume":"6","author":"J den Haan","year":"2017","unstructured":"den Haan, J., Verbraak, F. D., Visser, P. J. & Bouwman, F. H. Retinal thickness in alzheimer\u2019s disease: A systematic review and meta-analysis. Alzheimer\u2019s Dement. Diagnosis Assess. Dis. Monit. 6, 162\u2013170. https:\/\/doi.org\/10.1016\/j.dadm.2016.12.014 (2017).","journal-title":"Alzheimer\u2019s Dement. Diagnosis Assess. Dis. Monit."},{"key":"35383_CR61","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.ophtha.2018.08.009","volume":"126","author":"VTT Chan","year":"2019","unstructured":"Chan, V. T. T. et al. Spectral-Domain OCT measurements in alzheimer\u2019s disease: A systematic review and Meta-analysis. Ophthalmology 126, 497\u2013510. https:\/\/doi.org\/10.1016\/j.ophtha.2018.08.009 (2019).","journal-title":"Ophthalmology"},{"key":"35383_CR62","doi-asserted-by":"publisher","first-page":"106036","DOI":"10.1016\/j.clineuro.2020.106036","volume":"196","author":"AM Noah","year":"2020","unstructured":"Noah, A. M., Almghairbi, D. & Moppett, I. K. Optical coherence tomography in mild cognitive impairment \u2013 Systematic review and meta-analysis. Clin. Neurol. Neurosurg. 196, 106036. https:\/\/doi.org\/10.1016\/j.clineuro.2020.106036 (2020).","journal-title":"Clin. Neurol. Neurosurg."},{"key":"35383_CR63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/dad2.12421","volume":"15","author":"G Ashraf","year":"2023","unstructured":"Ashraf, G. et al. Retinal imaging biomarkers of alzheimer\u2019s disease: A systematic review and meta-analysis of studies using brain amyloid beta status for case definition. Alzheimer\u2019s Dement. Diagnosis Assess. Dis. Monit. 15, 1\u201318. https:\/\/doi.org\/10.1002\/dad2.12421 (2023).","journal-title":"Alzheimer\u2019s Dement. Diagnosis Assess. Dis. Monit."},{"key":"35383_CR64","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1097\/WNO.0000000000001140","volume":"41","author":"H Jiang","year":"2021","unstructured":"Jiang, H. et al. Retinal microvascular alterations as the biomarkers for alzheimer disease: are we there yet? J. Neuro-Ophthalmology. 41, 251\u2013260. https:\/\/doi.org\/10.1097\/WNO.0000000000001140 (2021).","journal-title":"J. Neuro-Ophthalmology"},{"key":"35383_CR65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fnins.2021.731614","volume":"15","author":"H Shi","year":"2021","unstructured":"Shi, H. et al. Retinal vasculopathy in alzheimer\u2019s disease. Front. Neurosci. 15, 1\u201313. https:\/\/doi.org\/10.3389\/fnins.2021.731614 (2021).","journal-title":"Front. Neurosci."},{"key":"35383_CR66","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1136\/jnnp-2015-310521","volume":"87","author":"S Balestrini","year":"2016","unstructured":"Balestrini, S. et al. Retinal nerve fibre layer thinning is associated with drug resistance in epilepsy. J. Neurol. Neurosurg. Psychiatry. 87, 396\u2013401. https:\/\/doi.org\/10.1136\/jnnp-2015-310521 (2016).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"35383_CR67","doi-asserted-by":"publisher","unstructured":"Garcia-Martin, E. et al. Fibromyalgia is correlated with retinal nerve fiber layer thinning. PLoS One. 11 https:\/\/doi.org\/10.1371\/journal.pone.0161574 (2016).","DOI":"10.1371\/journal.pone.0161574"},{"key":"35383_CR68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-019-56387-x","volume":"9","author":"JS Lee","year":"2019","unstructured":"Lee, J. S. et al. Risk factors associated with progressive nerve fiber layer thinning in open-angle glaucoma with mean intraocular pressure below 15 mmhg. Sci. Rep. 9, 1\u20137. https:\/\/doi.org\/10.1038\/s41598-019-56387-x (2019).","journal-title":"Sci. Rep."},{"key":"35383_CR69","doi-asserted-by":"publisher","first-page":"3216","DOI":"10.1007\/s00415-021-10936-5","volume":"269","author":"KA Woo","year":"2022","unstructured":"Woo, K. A. et al. Peripapillary retinal nerve fiber layer thinning in patients with progressive supranuclear palsy. J. Neurol. 269, 3216\u20133225. https:\/\/doi.org\/10.1007\/s00415-021-10936-5 (2022).","journal-title":"J. Neurol."},{"key":"35383_CR70","doi-asserted-by":"crossref","unstructured":"Frangi, A. F., Niessen, W. J., Vincken, K. L. & Viergever, M. A. Multiscale Vessel Enhancement Filtering pp 130\u2013137 (In: Springer, 1998).","DOI":"10.1007\/BFb0056195"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-35383-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-35383-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-35383-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T10:39:57Z","timestamp":1770287997000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-35383-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,13]]},"references-count":70,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["35383"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-35383-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,13]]},"assertion":[{"value":"19 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5083"}}